HCA Healthcare Shares Outstanding 2012-2026 | HCA
HCA Healthcare shares outstanding history from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- HCA Healthcare shares outstanding for the quarter ending June 30, 2026 were 0.223B, a 7.89% decline year-over-year.
- HCA Healthcare 2025 shares outstanding were 0.239B, a 8.52% decline from 2024.
- HCA Healthcare 2024 shares outstanding were 0.262B, a 5.28% decline from 2023.
- HCA Healthcare 2023 shares outstanding were 0.276B, a 6.19% decline from 2022.
|
HCA Healthcare Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 239 |
| 2024 | 262 |
| 2023 | 276 |
| 2022 | 295 |
| 2021 | 329 |
| 2020 | 344 |
| 2019 | 348 |
| 2018 | 355 |
| 2017 | 372 |
| 2016 | 396 |
| 2015 | 427 |
| 2014 | 450 |
| 2013 | 462 |
| 2012 | 459 |
| 2011 | 496 |
|
HCA Healthcare Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-06-30 | 223 |
| 2026-03-31 | 227 |
| 2025-12-31 | 239 |
| 2025-09-30 | 236 |
| 2025-06-30 | 242 |
| 2025-03-31 | 249 |
| 2024-12-31 | 262 |
| 2024-09-30 | 260 |
| 2024-06-30 | 264 |
| 2024-03-31 | 268 |
| 2023-12-31 | 276 |
| 2023-09-30 | 275 |
| 2023-06-30 | 278 |
| 2023-03-31 | 281 |
| 2022-12-31 | 295 |
| 2022-09-30 | 290 |
| 2022-06-30 | 296 |
| 2022-03-31 | 307 |
| 2021-12-31 | 329 |
| 2021-09-30 | 324 |
| 2021-06-30 | 333 |
| 2021-03-31 | 343 |
| 2020-12-31 | 344 |
| 2020-09-30 | 343 |
| 2020-06-30 | 342 |
| 2020-03-31 | 344 |
| 2019-12-31 | 348 |
| 2019-09-30 | 347 |
| 2019-06-30 | 348 |
| 2019-03-31 | 350 |
| 2018-12-31 | 355 |
| 2018-09-30 | 354 |
| 2018-06-30 | 355 |
| 2018-03-31 | 360 |
| 2017-12-31 | 372 |
| 2017-09-30 | 370 |
| 2017-06-30 | 375 |
| 2017-03-31 | 380 |
| 2016-12-31 | 396 |
| 2016-09-30 | 390 |
| 2016-06-30 | 399 |
| 2016-03-31 | 411 |
| 2015-12-31 | 427 |
| 2015-09-30 | 426 |
| 2015-06-30 | 429 |
| 2015-03-31 | 435 |
| 2014-12-31 | 450 |
| 2014-09-30 | 447 |
| 2014-06-30 | 453 |
| 2014-03-31 | 457 |
| 2013-12-31 | 462 |
| 2013-09-30 | 464 |
| 2013-06-30 | 463 |
| 2013-03-31 | 462 |
| 2012-12-31 | 459 |
| 2012-09-30 | 460 |
| 2012-06-30 | 459 |
| 2012-03-31 | 458 |
| 2011-12-31 | 496 |
| 2011-09-30 | 528 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $92.600B | $75.600B |
| HCA Healthcare Inc. is a provider of healthcare services comprising hospitals and ambulatory sites of care including surgery centers, freestanding ERs, urgent care centers and physician clinics. HCA Healthcare Inc., formerly known as HCA HOLDINGS, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.899B | 26.08 |
| CVS Health (CVS) | United States | $113.624B | 11.33 |
| Elevance Health (ELV) | United States | $89.122B | 13.98 |
| Cencora (COR) | United States | $58.924B | 18.00 |
| Natera (NTRA) | United States | $53.245B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.010B | 18.34 |
| Viatris (VTRS) | United States | $19.469B | 6.73 |
| Medpace Holdings (MEDP) | United States | $17.091B | 35.89 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.888B | 0.00 |
| DiDi Global (DIDIY) | China | $16.776B | 184.00 |
| Revvity (RVTY) | United States | $16.007B | 26.81 |
| Solventum (SOLV) | United States | $15.123B | 12.51 |
| Charles River Laboratories (CRL) | United States | $13.274B | 28.09 |
| ICON (ICLR) | Ireland | $12.565B | 17.08 |
| BrightSpring Health Services (BTSG) | United States | $11.235B | 38.63 |
| Avantor (AVTR) | United States | $10.497B | 18.93 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.472B | 83.28 |
| HealthEquity (HQY) | United States | $7.870B | 25.64 |
| Sonic Healthcare (SKHHY) | Australia | $6.732B | 0.00 |
| PACS (PACS) | United States | $6.666B | 22.40 |
| GETINGE (GNGBY) | Sweden | $6.516B | 18.40 |
| CochLear (CHEOY) | Australia | $6.200B | 0.00 |
| MiniMed (MMED) | United States | $6.131B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.021B | 22.77 |
| Sotera Health (SHC) | United States | $5.345B | 22.04 |
| Concentras Parent (CON) | United States | $4.523B | 22.31 |
| Organon (OGN) | United States | $3.592B | 4.56 |
| GeneDx Holdings (WGS) | United States | $3.015B | 280.83 |
| CareDx (CDNA) | United States | $2.785B | 316.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.465B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.107B | 12.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.103B | 0.00 |
| Progyny (PGNY) | United States | $2.082B | 29.49 |
| Establishment Labs Holdings (ESTA) | United States | $2.065B | 0.00 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $2.011B | 12.08 |
| Sonida Senior Living (SNDA) | United States | $1.839B | 0.00 |
| Freenome (FRNM) | United States | $1.838B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.735B | 66.25 |
| Alignment Healthcare (ALHC) | United States | $1.732B | 43.95 |
| Agilon Health (AGL) | United States | $1.497B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Ardent Health (ARDT) | United States | $1.478B | 8.45 |
| Nutex Health (NUTX) | United States | $1.430B | 8.20 |
| Omada Health (OMDA) | United States | $1.251B | 255.38 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.158B | 22.53 |
| Teladoc Health (TDOC) | United States | $1.145B | 0.00 |
| CryoPort (CYRX) | United States | $0.862B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.677B | 0.00 |
| Forward Industries (FWDI) | United States | $0.569B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 10.11 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.378B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.48 |
| Biodesix (BDSX) | United States | $0.308B | 0.00 |
| Embecta (EMBC) | United States | $0.300B | 2.59 |
| So-Young (SY) | China | $0.279B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.101B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.082B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.073B | 8.67 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.036B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |